Esterification of 8,11,14-eicosatrienoate and arachidonate into alkylacyl- and diacylglycerophosphocholine by vascular endothelial cells

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Lipids

• Publication date

  1988-11-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF02535658PMID 3148797
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 1-ether-linked phosphoglycerides. Major endogenous sources of arachidonate in the human neutrophil.

  1988cited by this paper
• Release of arachidonic acid from vascular endothelial cells: Fatty acyl specificity is observed with receptor‐mediated agonists and with the calcium ionophore A23187 but not with melittin

  1988cited by this paper
• Ionophore-induced metabolism of phospholipids and eicosanoid production in porcine aortic endothelial cells: selective release of arachidonic acid from diacyl and ether phospholipids.

  1987cited by this paper
• Pathways of arachidonic acid liberation in thrombin and calcium ionophore A23187-stimulated human endothelial cells: respective roles of phospholipids and triacylglycerol and evidence for diacylglycerol generation from phosphatidylcholine.

  1987cited by this paper
• Apparent specificity of the thrombin-stimulated deacylation of endothelial glycerolipids for polyunsaturated fatty acids with a delta-5 desaturation.

  1987cited by this paper
• Fatty acid composition of diacyl, alkylacyl, and alkenylacyl phospholipids of control and arachidonate-depleted rat polymorphonuclear leukocytes.

  1987cited by this paper
• Some unique features of the metabolic conversion of platelet-activating factor (AGEPC) to alkyl acyl PC by washed rabbit platelets.

  1987cited by this paper
• Elongation of arachidonic and eicosapentaenoic acids limits their availability for thrombin-stimulated release from the glycerolipids of vascular endothelial cells.

  1986cited by this paper
• Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells.

  1986cited by this paper
• Composition and incorporation of [3H]arachidonic acid into molecular species of phospholipid classes by cultured human endothelial cells.

  1986cited by this paper
• Platelet activating factor: a biologically active phosphoglyceride.

  1986cited by this paper
• Phospholipid (diacyl, alkylacyl, alkenylacyl) and fatty acyl chain composition in murine mastocytoma cells.

  1985cited by this paper
• Inactivation of platelet activating factor by rabbit platelets. Lyso-platelet activating factor as a key intermediate with phosphatidylcholine as the source of arachidonic acid in its conversion to a tetraenoic acylated product.

  1985cited by this paper
• Acylation of lysophospholipids by rabbit alveolar macrophages. Specificities of CoA-dependent and CoA-independent reactions.

  1985cited by this paper
• Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate.

  1985cited by this paper
• Chemical and biochemical aspects of platelet activating factor: A novel class of acetylated ether‐linked choline‐phospholipids

  1985cited by this paper
• Prostacyclin synthesis and deacylation of phospholipids in human endothelial cells: comparison of thrombin, histamine and ionophore A23187.

  1985cited by this paper
• 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes.

  1984cited by this paper
• Novel quantitative method for determination of molecular species of phospholipids and diglycerides.

  1984cited by this paper
• 1-O-alkyl-linked glycerophospholipids of human neutrophils: distribution of arachidonate and other acyl residues in the ether-linked and diacyl species.

  1984cited by this paper
• Release of arachidonic acid from 1-alkyl-2-acyl-sn-glycero-3-phosphocholine, a precursor of platelet-activating factor, in rat alveolar macrophages.

  1984cited by this paper
• Arachidonoyl transacylase in human platelets. Coenzyme A-independent transfer of arachidonate from phosphatidylcholine to lysoplasmenylethanolamine.

  1983cited by this paper
• 1-O-alkyl-2-acyl-sn-glycero-3-phosphocholine: a novel source of arachidonic acid in neutrophils stimulated by the calcium ionophore A23187.

  1983cited by this paper
• Selective acylation of lyso platelet activating factor by arachidonate in human neutrophils.

  1983cited by this paper
• Ether phospholipids in guinea pig polymorphonuclear leukocytes and macrophages. Occurrence of high levels of 1-O-alkyl-2-acyl-sn-glycero-3-phosphocholine.

  1982cited by this paper
• Selective utilization of ω 6 and ω 3 polyunsaturated fatty acids by human skin fibroblasts

  1982cited by this paper
• Enzymatic synthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine, a hypotensive and platelet-aggregating lipid.

  1980cited by this paper
• Culture of human endothelial cells.

  1980cited by this paper
• Quantitative extraction of microgram amounts of lipid from cultured human cells.

  1977cited by this paper
• Effect of phospholipase C hydrolysis of membrane phospholipids on membranous enzymes.

  1972cited by this paper

• Differential metabolism of dihomo-gamma-linolenic acid and arachidonic acid by cyclo-oxygenase-1 and cyclo-oxygenase-2: implications for cellular synthesis of prostaglandin E1 and prostaglandin E2.

  2002cites this paper
• Acyl specificity of phospholipases A 2 and C in thrombin-stimulated human platelets

  2002cites this paper
• [The pathogenetic significance of disruption of antioxidant homeostasis status in patients with hypertension].

  2000cites this paper
• C20 polyunsaturated fatty acids and phorbol myristate acetate enhance agonist-stimulated synthesis of 1-radyl-2-acetyl-sn-glycero-3-phosphocholine in vascular endothelial cells.

  1991cites this paper
• Regulation of agonist-induced prostaglandin E1 versus prostaglandin E2 production. A mass analysis.

  1991cites this paper
• Substrate specificity of the agonist-stimulated release of polyunsaturated fatty acids from vascular endothelial cells.

  1989cites this paper